ABSTRACT
Abstract: During the corona virus disease 2019 prevention and control period, based on the conscientiously studying the relevant documents issued by the National Health Protection Committee and the hospital infection department, and combining the characteristics of the neurological diseases and the actual work situation, the neurology ward reasonably set up three districts and two channels, ensure the adequacy and accessibility of the protective products, establish a comprehensive and detailed identification management, Strengthen the standardized training of staff, improve the relevant system, standardize the work process;strengthen the management of patients during admission and hospitalization, pay attention to the symptomatic nursing of patients, and strengthen the predictive nursing of various complications. From three levels of overall management (environment, staffs, patients), the spread of new coronavirus in the department of neurology was curbed effectively.
ABSTRACT
The COVID-19 pandemic has taken a significant toll on people worldwide, and there are currently no specific antivirus drugs or vaccines. We report herein a therapeutic based on catalase, an antioxidant enzyme that can effectively breakdown hydrogen peroxide and minimize the downstream reactive oxygen species, which are excessively produced resulting from the infection and inflammatory process. Catalase assists to regulate production of cytokines, protect oxidative injury, and repress replication of SARS-CoV-2, as demonstrated in human leukocytes and alveolar epithelial cells, and rhesus macaques, without noticeable toxicity. Such a therapeutic can be readily manufactured at low cost as a potential treatment for COVID-19.